GlassScriptPhysician profile
Paul Stephen Lin
NPI 1629047246
$2,891.88
in general payments reported to CMS, 2019-2025
17 companies · $642 in 2025
The $642 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $229 · 2021: $12.06 · 2022: $249 · 2023: $454 · 2024: $662 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,293.81 | 2019-2025 | Evenity, Prolia, Prolia |
| Radius Health, INC. | $656.31 | 2019-2025 | Tymlos |
| Vertos Medical, INC. | $193.29 | 2024 | Mild Device Kit |
| Medtronic, INC. | $172.87 | 2023 | Intellis Adaptivestim |
| Stryker Corporation | $118.33 | 2025 | Gamma |
| Ferring Pharmaceuticals INC. | $98.05 | 2023-2025 | Euflexxa |
| Kyowa Kirin, INC. | $71.56 | 2023-2025 | Crysvita |
| Bioventus LLC | $53.77 | 2020-2025 | Durolane |
| Pacira Therapeutics, INC. | $46.36 | 2019-2020 | |
| Tersera Therapeutics LLC | $40.02 | 2019 | |
| Merck Sharp & Dohme LLC | $33.35 | 2022-2023 | Bridion |
| Pacira Pharmaceuticals Incorporated | $29.02 | 2023 | Iovera |
| Depuy Synthes Sales INC. | $23.62 | 2019 | |
| Boston Scientific Corporation | $19.07 | 2023 | |
| Si-Bone, INC. | $16.52 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $13.87 | 2019 | |
| Globus Medical, INC. | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.